Adam J. Townsend
CIK 1773588 · Chief Commercial Officer · last filed 2025-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
34
Lifetime Open-Market Net
-$13.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Commercial Officer | 84,050 | $41.03 | $3.45M | -$13.31M | 34 | 2025-01-30 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-25 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +26,051 | $0 | EDGAR |
| 2021-02-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −688 | -$32.8K | EDGAR |
| 2021-02-01 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +9,375 | $0 | EDGAR |
| 2020-02-12 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +9,375 | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.